Lutathera therapy treatment for neuroendocrine tumours (NETs) is provided at the Beatson West of Scotland Cancer Centre in Glasgow.
What is the Lutathera Therapy Service?
The service provides in-patient and follow-up treatment to people with small bowel NETs that are somatostatin receptor (SSR) positive. Lutathera therapy slows down the growth of tumours, or prevents them from growing altogether.
After each treatment, a post-therapy nuclear medicine scan assesses distribution of the Lutathera. Follow-up care will continue to be provided jointly by the patient’s local team and the national service.